These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16288443)

  • 1. Extracorporeal blood oxygenation and ozonation (EBOO): a controlled trial in patients with peripheral artery disease.
    Di Paolo N; Bocci V; Salvo DP; Palasciano G; Biagioli M; Meini S; Galli F; Ciari I; Maccari F; Cappelletti F; Di Paolo M; Gaggiotti E
    Int J Artif Organs; 2005 Oct; 28(10):1039-50. PubMed ID: 16288443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracorporeal blood oxygenation and ozonation (EBOO) in man. preliminary report.
    Di Paolo N; Bocci V; Garosi G; Borrelli E; Bravi A; Bruci A; Aldinucci C; Capotondo L
    Int J Artif Organs; 2000 Feb; 23(2):131-41. PubMed ID: 10741810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracorporeal blood oxygenation and ozonation: clinical and biological implications of ozone therapy.
    Di Paolo N; Gaggiotti E; Galli F
    Redox Rep; 2005; 10(3):121-30. PubMed ID: 16156950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Necrotizing fasciitis successfully treated with extracorporeal blood oxygenation and ozonization (EBOO).
    Di Paolo N; Bocci V; Cappelletti F; Petrini G; Gaggiotti E
    Int J Artif Organs; 2002 Dec; 25(12):1194-8. PubMed ID: 12518965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood coagulation unaffected by ozonated autohemotherapy in patients on maintenance hemodialysis.
    Biedunkiewicz B; Lizakowski S; Tylicki L; Skiboeska A; Nieweglowski T; Chamienia A; Debska-Slizien A; Rutkowski B
    Arch Med Res; 2006 Nov; 37(8):1034-7. PubMed ID: 17045123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperbaric oxygen, oxygen-ozone therapy, and rheologic parameters of blood in patients with peripheral occlusive arterial disease.
    Verrazzo G; Coppola L; Luongo C; Sammartino A; Giunta R; Grassia A; Ragone R; Tirelli A
    Undersea Hyperb Med; 1995 Mar; 22(1):17-22. PubMed ID: 7742706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful lower extremity angioplasty improves brachial artery flow-mediated dilation in patients with peripheral arterial disease.
    Husmann M; Dörffler-Melly J; Kalka C; Diehm N; Baumgartner I; Silvestro A
    J Vasc Surg; 2008 Nov; 48(5):1211-6. PubMed ID: 18771886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxygenation-ozonation of blood during extracorporeal circulation: in vitro efficiency of a new gas exchange device.
    Bocci V; Zanardi I; Travagli V; Di Paolo N
    Artif Organs; 2007 Sep; 31(9):743-8. PubMed ID: 17725702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-year cardiovascular events and disease progress in patients with peripheral arterial disease: results from the Japan Medication Therapy for Peripheral Arterial Disease (J-METHOD).
    Shigematsu H; Nishibe T; Obitsu Y; Matsuzaki K; Ishida A; Miyata T; Shindo S; Hida K; Ohta T; Ando M; Kawasaki T; Yasugi T; Matsumoto T
    Int Angiol; 2010 Apr; 29(2 Suppl):2-13. PubMed ID: 20357743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of selective AT1-receptor blockade versus ACE inhibition for restenosis prophylaxis in patients with peripheral occlusive arterial disease after stent angioplasty: a randomized, controlled, proof-of-concept study.
    Schindler C; Mueller A; Bramlage P; Boecking W; Kirch W; Schweizer J
    Angiology; 2007 Dec-2008 Jan; 58(6):710-6. PubMed ID: 17928625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy of ozonated autohemotherapy in hemodialyzed patients with intermittent claudication: an oxygen-controlled study.
    Biedunkiewicz B; Tylicki L; Nieweglowski T; Burakowski S; Rutkowski B
    Int J Artif Organs; 2004 Jan; 27(1):29-34. PubMed ID: 14984181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fistula function and dialysis adequacy during ozonotherapy in chronically hemodialyzed patients.
    Tylicki L; Biedunkiewicz B; Nieweglowski T; Grabowska M; Chamienia A; Slizien AD; Rutkowski B
    Artif Organs; 2004 May; 28(5):513-7. PubMed ID: 15156869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial clinical effects of ozonated autohemotherapy in chronically dialysed patients with atherosclerotic ischemia of the lower limbs--pilot study.
    Tylicki L; Niew głowski T; Biedunkiewicz B; Burakowski S; Rutkowski B
    Int J Artif Organs; 2001 Feb; 24(2):79-82. PubMed ID: 11256512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
    Maksimović ZV
    Srp Arh Celok Lek; 1999; 127(7-8):249-53. PubMed ID: 10624398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostacyclin for ischemic ulcers in peripheral arterial disease. A random assignment, placebo controlled study.
    Nizankowski R; Królikowski W; Bielatowicz J; Szczeklik A
    Thromb Res; 1985 Jan; 37(1):21-8. PubMed ID: 3885472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasogen's immune modulation therapy (IMT) improves postischemic foot skin blood flow and transcutaneous pO(2) recovery rates in patients with advanced peripheral arterial occlusive disease.
    Edvinsson LI; Edvinsson ML; Angus Deveber G
    Int Angiol; 2003 Jun; 22(2):141-7. PubMed ID: 12865879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spinal cord stimulation in hemodialysis patients with critical lower-limb ischemia.
    Brümmer U; Condini V; Cappelli P; Di Liberato L; Scesi M; Bonomini M; Costantini A
    Am J Kidney Dis; 2006 May; 47(5):842-7. PubMed ID: 16632023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hybrid surgical and endovascular therapy in multifocal peripheral TASC D lesions: up to three-year follow-up.
    Nishibe T; Kondo Y; Dardik A; Muto A; Koizumi J; Nishibe M
    J Cardiovasc Surg (Torino); 2009 Aug; 50(4):493-9. PubMed ID: 19734834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical treatment of peripheral arterial disease: a comprehensive review.
    Stoyioglou A; Jaff MR
    J Vasc Interv Radiol; 2004 Nov; 15(11):1197-207. PubMed ID: 15525738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporary inhibition of platelet function with iloprost (ZK36374) preserves canine platelets during extracorporeal membrane oxygenation.
    Cottrell ED; Kappa JR; Stenach N; Fisher CA; Tuszynski GP; Switalska HI; Addonizio VP
    J Thorac Cardiovasc Surg; 1988 Oct; 96(4):535-41. PubMed ID: 2459560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.